Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fukunishi, I.
* Articles by Fukutake, K.
* Search for Related Content
PubMed
* Articles by Fukunishi, I.
* Articles by Fukutake, K.
Related Collections
* Other Patient Groups/Issues
* AIDS/HIV
* Miscellaneous Mood Disorders
Psychosomatics 40:529, December 1999
© 1999 The Academy of Psychosomatic Medine


Letter

CD4 Counts of HIV-Positive Patients With Cognitive Disorders in Japan

Isao Fukunishi, M.D., Naotsugu Hirabayashi, M.D., and Katsuyuki Fukutake, M.D., Tokyo Metropolitan Organization for Medical Research, Tokyo Institute of Psychiatry, Departments of Neuropsychiatry and Clinical Pathology, Tokyo Medical College, Tokyo, Japan

Key Words: Letters to the Editor • HIV • Cognitive Disorders

TO THE EDITOR: The total number of human immunodeficiency virus (HIV)-positive patients is still relatively low in Japan (4,312 HIV-positive patients and 1,427 acquired immunodeficiency syndrome [AIDS] patients as of February 1999),1 compared with the United States, and the majority of HIV-positive patients are concentrated in the Tokyo metropolitan area. Therefore, consultation-liaison psychiatrists who belong to the reserved general hospitals in Tokyo dealing with HIV-positive patients frequently see associated psychiatric problems, including mood and cognitive disorders. We examined the incidence rate of psychiatric disorders over 1 year (1997) and the relationship between CD4 counts and cognitive disorders in a sample of 179 HIV-positive patients consisting of 106 patients without and 73 patients with AIDS in Tokyo, Japan.

Eleven of the 40 reserved general hospitals in the Tokyo metropolitan area dealing with HIV-positive patients voluntarily participated in this study. The subjects were 179 HIV-positive patients (157 men and 20 women) and included 106 patients without and 73 patients with AIDS who were admitted to the participating general hospitals.

The sample size was about 4.2% of all HIV-positive patients and 5.1% of all AIDS patients living in Japan. This research constitutes the largest psychiatric study of HIV-positive patients in Japan to date.

After obtaining informed consent, psychiatric interviews were performed to examine the presence or absence of psychiatric disorders over 1 year. Psychiatric diagnoses were performed by using DSM-IV criteria based on the discussion of two liaison psychiatrists or psychologists. The psychiatric follow-up period was about 1 year.

The total incidence rate of psychiatric disorders was 29.6% (53 of 179 patients) in all HIV-positive patients. The incidence rate of psychiatric disorders was significantly higher for the patients with AIDS (47.9%) than for the patients without AIDS (18.9%) ({chi}2=16.1, df=1, P=0.001). This difference appears to be due to the dramatic increase in cognitive disorders after the onset of AIDS.

Among psychiatric disorders, the incidence rates for mood disorders and cognitive disorders ranked first (23.4%) and second (23.1%), respectively. The remaining psychiatric disorders were adjustment disorder (2.2%), substance abuse disorders (2.2%), and others (0.5%). No significant difference was observed between the incidence rates of mood disorders in the patients with (15.1%) and without AIDS (13.7%). The incidence rate of cognitive disorders was significantly higher for the patients with AIDS (28.8%) than for the patients without AIDS (1.1%) ({chi}2=23.3, df=1, P=0.001).

CD4 counts were found to be related to the incidence of cognitive disorders. A total of 1.8% (1 of 112) of the patients with CD4 counts less than 500/µl, 28.8% (21 of 73) of patients with counts less than 200/µl, over 40% (18 of 45) of the patients with counts less than 100/µl, and more than 45% (16 of 35) of the patients with counts less than 50/µl were diagnosed with cognitive disorders. The increase in the incidence rate of cognitive disorders with lower CD4 counts was statistically significant ({chi}2=52.8, df=3, P=0.0001). This finding suggests the possibility that the CD4 count may be a biological indicator predicting the manifestation of cognitive disorders, although other medical and psychiatric factors are also related to the development of cognitive disorders.2

REFERENCES

  1. AIDS Committee of Japan: Informations in HIV-positive patients on Tokyo Metropolitan. Hand-in-hand AIDS Tokyo (newsletter) 1999, 7, pp. 1–2
  2. Stern Y, Liu X, Marder K, et al: Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without infection. Neurology 1995; 45:467–472[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Psychosom. Med.Home page
S. B. Harvey, M. Wadsworth, S. Wessely, and M. Hotopf
Etiology of Chronic Fatigue Syndrome: Testing Popular Hypotheses Using a National Birth Cohort Study
Psychosom Med, May 1, 2008; 70(4): 488 - 495.
[Abstract] [Full Text] [PDF]


This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fukunishi, I.
* Articles by Fukutake, K.
* Search for Related Content
PubMed
* Articles by Fukunishi, I.
* Articles by Fukutake, K.
Related Collections
* Other Patient Groups/Issues
* AIDS/HIV
* Miscellaneous Mood Disorders


Get information about faster international access.

Privacy Policy

Copyright © 1999 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org